A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

Former President Joe Biden completed a course of radiation therapy to treat his prostate cancer on Monday. Biden’s daughter, ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid ...

New findings from the EMBARK trial reveal enzalutamide significantly reduces mortality risk in high-risk prostate cancer ...

Former President Joe Biden, 82, completed a round of radiation therapy for aggressive prostate cancer. He received treatment ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.

Among 804 androgen receptor pathway inhibitor-experienced mCRPC patients, 459 patients (57.1%) received another androgen receptor pathway inhibitor as their index therapy and 192 (23.9%) received ...

Former President Joe Biden has completed a course of radiation therapy as he battles prostate cancer, a spokesperson for ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...

Men with prostate cancer that returns after surgery or radiation and are left with few options could benefit from a new ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...